RECRUITING

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).

Official Title

Increasing Physical Activity Via Provider Prescription and Engagement: Efficacy of ExerciseRx for Adults With Multiple Sclerosis (MS)

Quick Facts

Study Start:2024-02-16
Study Completion:2026-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06270641

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Provider-confirmed diagnosis of MS using revised 2017 McDonald criteria
  2. * \> 18+ years of age
  3. * Patient determined disease steps (PDDS) score \< 3, indicating the potential for some gait disability although typically ambulates without an assistive device
  4. * Insufficiently active, defined as \< 150 minutes of physical activity per week, assessed using the PAVS in the EHR in clinics as part of the routine patient intake process
  5. * Use of an iPhone with software version iOS13+ or an Android phone 4.1+
  6. * Agree to install and use the ExerciseRx app for the entire study period and keep their phone on them during the daytime (e.g., pocket, bags, hands)
  1. * Recent (past 4 weeks) or planned surgery during the study period which may impact engaging in step counts
  2. * MS relapse within the last 30 days
  3. * Plans to travel internationally during the study period, which could interfere with server uploads of mobile phone data
  4. * Those at a higher risk of falling or injury from falls or unable to safely exercise due to other medical conditions (e.g. heart conditions, diabetes or conditions made worse by walking or physical activity)

Contacts and Locations

Study Contact

Laurie Kavanagh, MPH
CONTACT
206-668-4168
lauriek@uw.edu

Principal Investigator

Dawn Ehde, PhD
PRINCIPAL_INVESTIGATOR
UW Medicine

Study Locations (Sites)

UW Medicine
Seattle, Washington, 98133
United States

Collaborators and Investigators

Sponsor: University of Washington

  • Dawn Ehde, PhD, PRINCIPAL_INVESTIGATOR, UW Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-16
Study Completion Date2026-09-30

Study Record Updates

Study Start Date2024-02-16
Study Completion Date2026-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Multiple Sclerosis (MS)
  • Fatigue
  • Physical Inactivity